GSK plc announced today that the US Food and Drug Administration (FDA) has given the green light to AREXVY (Respiratory Syncytial Virus (RSV) Vaccine, Adjuvanted) for the prevention of RSV…
GSK plc (LSE/NYSE: GSK) announced today that the US Food and Drug Administration (FDA) has granted approval for AREXVY (Respiratory Syncytial Virus (RSV) Vaccine, Adjuvanted) to prevent RSV lower respiratory…
MAIA Biotechnology, Inc. (NYSE American: MAIA), a clinical-stage enterprise dedicated to developing telomere-targeting immunotherapies for cancer, has celebrated the validation of clinical and regulatory pathways for effective therapies leveraging the…
Genentech, a member of the Roche Group, shared today groundbreaking 5-year findings reaffirming the lasting effectiveness and safety of Evrysdi® (risdiplam) in children diagnosed with Type 1 spinal muscular atrophy…
Arcturus Therapeutics Holdings Inc. (Nasdaq: ARCT), a global leader in messenger RNA medicines, focused on addressing unmet medical needs in infectious diseases and rare liver and respiratory conditions, unveiled Phase…
The “Contact Layer Dressings Market – A Global and Regional Analysis: Focus on Region, Country-Level Analysis, and Competitive Landscape – Analysis and Forecast, 2023-2030” report has been added to ResearchAndMarkets.com’s offering. The global contact…
Helix, a prominent population genomics company, has introduced new clinico-genomic datasets aimed at empowering life science firms in advancing precision medicine drug discovery and development. These datasets, cultivated through Helix’s…
The “Global Automated Liquid Handling Systems Market – Outlook & Forecast 2024-2029” report is now available from ResearchAndMarkets.com. The market is projected to grow from $1.46 billion in 2023 to…
UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company focused on developing and commercializing innovative treatments for urothelial and specialty cancers, today announced the granting of inducement restricted stock units (RSUs)…
BWXT Medical Ltd. has submitted a Drug Master File (DMF) to the U.S. Food and Drug Administration (FDA) for No Carrier Added (n.c.a.) Actinium-225 (Ac-225) Active Pharmaceutical Ingredient. Ac-225 is…
Today, Vertex Pharmaceuticals announced the presentation of new data on TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor), known in the European Union and the U.K. as KAFTRIO® (ivacaftor/tezacaftor/elexacaftor) in combination with ivacaftor, at…
Today, Lilly announced that Anat Ashkenazi, the company’s Chief Financial Officer (CFO), has resigned from her position to pursue a career opportunity outside the pharmaceutical industry. David A. Ricks, the…